Stephen Hitchcock
Director/Miembro de la Junta en Structural Genomics Consortium .
Origen de la red de primer grado Stephen Hitchcock.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Structural Genomics Consortium
Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services The Structural Genomics Consortium is a non-profit organization that accelerates research by sharing all of its research output with the scientific community without any restrictions. The private company is based in Headington, UK. The British company has created an open collaborative network of scientists in hundreds of universities worldwide and nine pharmaceutical companies. The company was founded by Pär Nordlund.
12
| Private Company | Miscellaneous Commercial Services | 12 |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA.
10
| Holding Company | Medical Specialties | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Stephen Hitchcock a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Notre Dame | College/University | Masters Business Admin | |
TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
McGill University | College/University | Doctorate Degree | |
McMaster University | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
University of California San Diego | College/University | Doctorate Degree | |
Trinity College Dublin | College/University | Doctorate Degree | |
University of Giessen | College/University | Undergraduate Degree | |
L.E.K. Consulting LLP
L.E.K. Consulting LLP Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting is a global strategy consulting firm that specializes in corporate strategy, transaction services, and performance improvement. Founded in 1983, L.E.K. currently employs over 900 professionals in 20 offices worldwide. Global clients include Fortune 500, FTSE 100, Eurotop 300, and many of the largest firms in Asia-Pacific. With a reputation for solving the most complex issues, L.E.K. collaborates with business leaders to accelerate the pace and precision of strategic decision-making. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Genome Canada
Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard Medical School | College/University | Graduate Degree | |
HLS Ingenieurbüro GmbH
HLS Ingenieurbüro GmbH Engineering & ConstructionIndustrial Services HLS Ingenieurbüro GmbH provides engineering services. The firm specializes in the bodywork sector of the automobile industry, assembly technology, the aerospace industry and rail vehicles. The company was founded in 1966 and is headquartered in Augsburg, Germany. | Engineering & Construction | Chief Executive Officer | |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
UC San Diego School of Medicine | College/University | Doctorate Degree | |
Dolby Family Ventures LLC
Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures (Dolby) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
UPMC Enterprises
UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Private Equity Investor | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Mindimmune Therapeutics, Inc.
Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mindimmune Therapeutics, Inc. develops drugs that target the immune system to treat diseases of the central nervous system. It focuses on the treatment of Alzheimer's, Huntington's disease, pain, and psychiatric disorders. The company was founded by Stevin Zorn, Frank S. Menniti, Robert B. Nelson, and Brian M. Campbell on July 12, 2016 and is headquartered in Kingston, RI. | Pharmaceuticals: Major | Director/Board Member | |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Director/Board Member | |
SYNLOGIC, INC. | Biotechnology | Chief Executive Officer | |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member | |
ELIEM THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Generian Pharmaceuticals, Inc.
Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Generian Pharmaceuticals, Inc. provides pharmaceutical services. The company is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director/Board Member | |
HLS SACHA GmbH
HLS SACHA GmbH Engineering & ConstructionIndustrial Services HLS SACHA GmbH engages in the provision of engineering services in the area of machine construction. It offers CAD, CAM, and CAE-based products and computer services; software development; custom manufacturing for the automotive industry; software and electronics design, including semiconductors and circuitry for the development of software for electronic products; as well as design, development, and production of machines and equipment. The company was founded on October 23, 2019 and is headquartered in Augsburg, Germany. | Engineering & Construction | Chief Executive Officer | |
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Foundation is a nonprofit organization that aims to help people lead healthy and productive lives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. The company's mission is to create a world where everyone has equal opportunities. The company is guided by the belief that every life has equal value. The foundation is currently working on 'the big catch-up' project, which aims to increase vaccination levels among children to pre-pandemic levels and strengthen primary healthcare services for essential immunization in the future. The company was founded by Melinda French Gates and William H. Gates, and the CEO is Mark Suzman. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Reservoir Neuroscience, Inc.
Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Reservoir Neuroscience, Inc. develops novel therapeutics. It focuses on treating dysfunctional blood vessels in the brain other neurological disorders. The company was founded by Aaron Friedman in 2019 and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Director/Board Member | |
Dementia Discovery Fund
Dementia Discovery Fund Investment ManagersFinance Part of SV Health Investors LLP, Dementia Discovery Fund is a venture capital fund. The company is based in London, UK. Founded in 2015, Dementia Discovery Fund operates as a venture capital fund. | Investment Managers | Corporate Officer/Principal | |
Libra Therapeutics, Inc.
Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Libra Therapeutics, Inc. operates as biotechnology company which develops novel disease-modifying therapeutics. It focuses on the areas of amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's, Parkinson's, and Huntington's disease. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Xenocor, Inc.
Xenocor, Inc. Medical SpecialtiesHealth Technology Xenocor, Inc. is a privately held corporation based in Utah that offers a suite of leading-edge, fog-free, disposable surgical technologies for minimally invasive, abdominal, and thoracic procedures. The American company also offers a suite of leading-edge, fog-free, single-use endoscopes for minimally invasive surgical procedures. These products emerged from the Center for Medical Innovation and are FDA cleared, CE marked, and patent protected. The company was founded by John Langell, Lane Brooks, and Sourav Kole, and the CEO is Evan Kelso. | Medical Specialties | Founder | |
Novasenta, Inc.
Novasenta, Inc. Miscellaneous Commercial ServicesCommercial Services Novasenta, Inc. develops therapies for cancer. The company is based in Pittsburgh, PA. The company was founded by Greg Delgoffe, Robert L. Ferris, Dario Vignali. Mani Mohindru has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
AviadoBio Ltd.
AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Paros Bio, Inc.
Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a private company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. The company is focused on developing a gene replacement approach to treat autosomal dominant Alzheimer's disease (ADAD). Specifically, they are working on a gene therapy that targets mutations in the presenilin 1 gene (PSEN1), which is the underlying genetic cause of ADAD. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 37 |
Reino Unido | 6 |
Canadá | 5 |
Alemania | 5 |
Irlanda | 2 |
Sectorial
Health Technology | 27 |
Consumer Services | 11 |
Commercial Services | 7 |
Finance | 6 |
Industrial Services | 3 |
Operativa
Director/Board Member | 77 |
Corporate Officer/Principal | 17 |
Chief Executive Officer | 17 |
Independent Dir/Board Member | 15 |
Founder | 8 |
Las relaciones más conectadas
Insiders | |
---|---|
Jason Lettmann | 21 |
Bradley Margus | 19 |
David Lubner | 19 |
Aoife Brennan | 12 |
Sourav Kole | 11 |
Robert Poole | 10 |
John Thompson | 9 |
Matthias Kleinz | 7 |
Laurence Barker | 5 |
Ulrich Betz | 4 |
Aled Edwards | 3 |
Mark Carlton | 3 |
Cindy Lea Bell | 3 |
Tetsuyuki Maruyama | 1 |
Trevor Howe | 1 |
- Bolsa de valores
- Insiders
- Stephen Hitchcock
- Conexiones Empresas